trimethoprim has been researched along with Emphysema, Mediastinal in 2 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, JY | 1 |
Kim, DM | 1 |
Kwon, YE | 1 |
Yoon, SH | 1 |
Lee, SI | 1 |
Fubini, SL | 1 |
Todhunter, RJ | 1 |
Vivrette, SL | 1 |
Hackett, RP | 1 |
2 other studies available for trimethoprim and Emphysema, Mediastinal
Article | Year |
---|---|
Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Humans; Male; Mediastinal Emphy | 2009 |
Tracheal rupture in two horses.
Topics: Animals; Anti-Infective Agents, Urinary; Bandages; Combined Modality Therapy; Drug Combinations; Emp | 1985 |